Table 1.
Demographic and histoclinical characteristics of breast cancer patients and normal controls
| Patient N (%)TNBC | Patient N (%)non-TNBC | Control N (%) | |
|---|---|---|---|
| Number | 46 | 50 | 50 |
| Age (years) | |||
| Mean | 48.6±11.5 | 41.5±10.4 | 48.5±16.4 |
| Range | 26–79 | 25–82 | 25–80 |
| Stage at diagnosis | |||
| Stage II | 30(65.2) | 30(60%) | |
| Stage III | 12(26.1%) | 16(32%) | |
| Stage IV | 4 (8.7%) | 4 (8%) | |
| Lymph node status | |||
| N0 | 24(52.2%) | 20 (40%) | |
| N+ | 22(47.8%) | 30(60%) | |
| Distance metastasis | |||
| Yes | 4 [bone] (8.7%) | 4[2bone, 2 lung] (8%) | |
| No | 42 (91.3%) | 46(98%) |
ER=estrogen receptor, PR=progesterone receptor, TNBC: triple negative breast cancer (ER-, PR-, HER2-), N= number.